Calendar

Events that a source expects, grouped by the month, quarter or half-year the source names, with who expected each and when they said so.

Upcoming as of , the date this release was built (the newest input commit date), not today's date. An expected date is a statement by the source, not a result, and it can move. Dated events are on the timeline.

8,817 of these dates come from registry records: the start, primary completion or completion that a registry expects of a trial. A program assembled them, and a registry often leaves a date unchanged after it has passed. The calendar file lists the dates of written pages only.

Add to your calendar (calendar.ics)

The calendar file has one all-day event for each upcoming item. Where a source gives only a month, a quarter, a half-year or a year, the event sits on the first day of that period and its title says "expected sometime in" the period.

Upcoming

December 2031 26

  1. Study completion Net Clinical Benefit of Edoxaban Versus Apixaban in Patients With Atrial Fibrillation and Coronary Artery Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07753200

  2. Primary completion TransCatheter Replacement Of the Mitral Valve With the Novel Cephea Mitral Valve System Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07798726

  3. Study completion Unimanual Versus Bimanual Motor Skill Learning in Acute and Chronic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07826832

January 2032 12

  1. Study completion Drug-Coated Balloon Versus Drug-Eluting Stent in Patient With ST-Segment Elevation Myocardial Infarction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06742125

  2. Primary completion Drug-Coated Balloon Versus Drug-Eluting Stent in Patient With ST-Segment Elevation Myocardial Infarction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06742125

  3. Study completion Evaluation of Branch Endografts in the Treatment of Aortic Aneurysms Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01524211

  4. Study completion Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05102019

  5. Study completion Effect of Visual Retraining After Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06121219

  6. Study completion Xeltis Hemodialysis Access Graft (aXess) US Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06494631

  7. Study completion Inter-Limb Transfer in Acute Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07822633

  8. Study completion Randomized Interventional Clinical Trial on the Prevention of Atrial Fibrillation Using Colchicine, Amiodarone And a Posterior Pericardiotomy. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07887022

  9. Primary completion LA-HCM Study : Rivaroxaban for Antithrombotic Prevention in Hypertrophic Cardiomyopathy Patients With Abnormal Left Atrial Strain. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07202897

  10. Study completion Efficacy and Safety of Tenecteplase Among acutE Ischemic Stroke Patients With Recent Ingestion of Direct Oral Anticoagulant Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07621796

  11. Primary completion Efficacy and Safety of Tenecteplase Among acutE Ischemic Stroke Patients With Recent Ingestion of Direct Oral Anticoagulant Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07621796

February 2032 10

  1. Primary completion Improving Mobility After Revascularization in Peripheral Artery Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06686121

  2. Study completion Oral Anticoagulation in Patients With Prior Deep Intracerebral Hemorrhage, Atrial Fibrillation, and Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07609654

  3. Study completion The Artisse™ Intrasaccular Device is Indicated for the Treatment of Wide-neck Bifurcating Intracranial Aneurysms (IAs). Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02998229

  4. Study completion Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05540223

  5. Study completion J-Valve Transfemoral Pivotal Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06455787

  6. Study completion 1 or 6 Months of Dual Antiplatelet Therapy After Drug-coated Balloon Angioplasty for De-novo Small Coronary Artery Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07592507

  7. Primary completion 1 or 6 Months of Dual Antiplatelet Therapy After Drug-coated Balloon Angioplasty for De-novo Small Coronary Artery Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07592507

  8. Study completion MetfOrmin BenefIts Lower Extremities With Intermittent Claudication Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05132439

  9. Study completion RCT of Implantable Defibrillators in Patients With Non Ischemic Cardiomyopathy, Scar and Severe Systolic Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05568069

  10. Study completion A Pivotal Investigational Device Exemption Study on Laminar Left Atrial Appendage Elimination Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06168942

March 2032 11

  1. Study completion Bioresorbable Sirolimus-Eluting Scaffold Treatment for Below the Knee Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06071429

  2. Study completion Penicillin to Prevent Early Rheumatic Heart Disease in School-Aged Children Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07798232

  3. Study completion Safety and Efficacy Study of reSept ASD Occluder for Treating Secundum ASD Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04591392

  4. Study completion JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05064540

  5. Primary completion JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05064540

  6. Study completion EARLY TAVR

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: EARLY TAVR: Evaluation of TAVR Compared to Surveillance for Patients With Asymptomatic Severe Aortic Stenosis

  7. Primary completion Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05682378

  8. Study completion Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05682378

  9. Study completion Prospective Multicenter Study Evaluating Myval TAVR Safety and Effectiveness in High-risk Severe AR Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07751965

  10. Study completion Statins to Prevent Cancer Associated Blood Clots Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07303816

  11. Primary completion LOw DosE Spironolactone, chlorThAlidone oR Combination in CKD Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07645300

April 2032 1

  1. Study completion Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05478304

May 2032 4

  1. Study completion CAAAs, TAAAs, Aortic Arch Aneurysms or Dissections With Fenestrated/Branched Stent Graft Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02089607

  2. Study completion Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05714085

June 2032 8

  1. Study completion ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04503395

  2. Study completion Digital Screening for Atrial Fibrillation to Prevent Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07684053

  3. Study completion Language Processing and TMS Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05425615

  4. Primary completion Language Processing and TMS Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05425615

  5. Primary completion Drug Eluting Temporary Spur Stent System vs Percutaneous Balloon Angioplasty for the Treatment of Critical Limb Ischemia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06122974

  6. Study completion The Prevent Coronary Artery Disease Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06494501

  7. Primary completion The Prevent Coronary Artery Disease Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06494501

  8. Study completion LOw DosE Spironolactone, chlorThAlidone oR Combination in CKD Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07645300

July 2032 8

  1. Study completion Surveillance of Pancreatic Health After Diabetes Diagnosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06803771

  2. Study completion Clinical Study to Evaluate the Safety and Effectiveness of Arcevo LSA Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07089576

  3. Study completion The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked Intracranial Aneurysms Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07143019

  4. Study completion Frailty and Physician Modified Fenestrated Endograft for Thoracoabdominal Aortic Pathologies Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04524247

  5. Study completion A Study to Evaluate the Safety and Efficacy of Mavacamten in Adults With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy (SOLSTICE-HCM) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07940777

  6. Study completion SELUTION4BTK Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05055297

  7. Study completion RELIEVE-HFrEF TRIAL: REducing Lung congestIon Symptoms Using the v-wavE Shunt in adVancEd Heart Failure With Reduced EF Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07696975

August 2032 3

  1. Study completion Temsirolimus Adventitial Delivery to Improve ANGioplasty and/or Atherectomy Revascularization Outcomes Below the Knee Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04433572

  2. Study completion Improving Mobility After Revascularization in Peripheral Artery Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06686121

  3. Study completion Safety and Effectiveness Study of DragonFly-T System for Severe Tricuspid Regurgitation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05556460

September 2032 2

  1. Study completion Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06526195

  2. Study completion TAVR vs. SAVR Study of VitaFlow Liberty® for Severe BAV Stenosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06597188

October 2032 7

  1. Primary completion The Effectiveness of Patch-Based Screening for Pre-Symptomatic Atrial Fibrillation to Improve Patient Outcome Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06953778

  2. Study completion A Danish ICD-study in Patients with Coronary Artery Disease Resuscitated from Ventricular Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04576130

  3. Primary completion A Danish ICD-study in Patients with Coronary Artery Disease Resuscitated from Ventricular Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04576130

  4. Study completion Guo&Amp;'s Distal Entry Tear Repair With WeFlow-EndoPatch System (Gallant Study) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06945809

  5. Study completion Virtue® SAB in the Treatment of Coronary ISR Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07045194

  6. Primary completion Comparing the Safety and Efficacy of Apixaban and Rivaroxaban Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06953726

  7. Study completion REstoring Flow by REvascularization With Submaximal Angioplasty in Hemodynamic IntraCranial Atherosclerotic Stenosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03729817

November 2032 4

  1. Study completion A Prospective, Randomized Multicenter Clinical Trial of the TricValve® Transcatheter Bicaval Valve System in Subjects With Severe Tricuspid Regurgitation. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06458907

  2. Study completion Elite AF IDE Trial (Elite AF) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07287436

  3. Study completion Strategies for the Management of Atrial Fibrillation in patiEnts Receiving Dialysis 2 (SAFE-D2) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07779746

  4. Study completion TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07052903

December 2032 19

  1. Study completion Alleviant ALLAY-HF Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05685303

  2. Primary completion Optimal PharmacoTherapy and Invasive Management of Atrial Fibrillation in Patients With Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07238452

  3. Study completion A Clinical Study of the Paradise™ Renal Denervation System in Patients With Hypertension (RADIANCE-HTN DUO) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05326230

  4. Study completion Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06563895

  5. Study completion International Study of Comparative Health Effectiveness With Medical and Invasive Approaches-Left Ventricular Dysfunction Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06566183

  6. Study completion The STTAR-US Study: A Pivotal Study of Transcatheter Tricuspid Annular Repair in the US Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06700239

  7. Study completion EXPLORE MRace (GE): Early Feasibility Experience of Posterior Leaflet Restoration to Reduce Mitral Regurgitation Using the MRace Implant Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07796659

  8. Primary completion EXPLORE MRace (GE): Early Feasibility Experience of Posterior Leaflet Restoration to Reduce Mitral Regurgitation Using the MRace Implant Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07796659

  9. Study completion Conduction System Pacing Versus Conventional Right Ventricular Pacing in Adults With Atrioventricular Block Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07945860

  10. Study completion People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03520660

  11. Primary completion People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03520660

  12. Study completion OPTIMIZE-APT: Tailored Versus Conventional Antiplatelet Therapy After Intravascular Imaging-guided Drug-eluting Stent Implantation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05418556

  13. Study completion Chronic Coronary Syndrome in Swedish Primary Care Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05782582

  14. Study completion Nectero EAST System Clinical Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06001918

  15. Primary completion MEdical Treatment in Idiopathic Ventricular Fibrillation Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07405229

  16. Study completion Dilated Cardiomyopathy - Unknown Therapeutic Risk Reduction by Contempary Medication and Implantable Cardioverter-Defibrillators (DUTCH-ICD) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07415642

  17. Primary completion Dilated Cardiomyopathy - Unknown Therapeutic Risk Reduction by Contempary Medication and Implantable Cardioverter-Defibrillators (DUTCH-ICD) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07415642

  18. Study completion A Novel Wire-Reinforced Fenestration of a Hybrid Frozen Elephant Trunk Device for Supra-Aortic Branch Vessel Stenting During Aortic Arch Replacement Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07885865

  19. Primary completion A Novel Wire-Reinforced Fenestration of a Hybrid Frozen Elephant Trunk Device for Supra-Aortic Branch Vessel Stenting During Aortic Arch Replacement Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07885865

January 2033 14

  1. Study completion Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03206060

  2. Study completion HD-tDCS for Phonological Impairment in Aphasia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06010030

  3. Primary completion HD-tDCS for Phonological Impairment in Aphasia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06010030

  4. Study completion Optimal PharmacoTherapy and Invasive Management of Atrial Fibrillation in Patients With Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07238452

  5. Primary completion PARTNER 3 Trial - Aortic Valve-in-Valve Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03003299

  6. Study completion Portico Next Generation Approval Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04011722

  7. Study completion Transcranial Alternating Current Stimulation (tACS) for the Recovery of Phonological Short-Term Memory in Patients With Aphasia After Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06048159

  8. Primary completion Transcranial Alternating Current Stimulation (tACS) for the Recovery of Phonological Short-Term Memory in Patients With Aphasia After Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06048159

Overdue

The expected date has passed and no published record says the event happened. This does not mean it failed or was delayed: the atlas may not have checked the source since. Oldest first.

  1. Primary completion Safety and Effectiveness of the Peripheral Balloon-Expandable Covered Stent System for Iliac Artery Stenosis/Occlusion. (SELECT) Registry record

    Expected 2026-07-15; that period ended on 2026-07-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06605209

  2. Study start Comparing the Efficacy and Safety of Vericiguat With Standard Medical Treatment in Heart Failure Patients Registry record

    Expected 2026-07-15; that period ended on 2026-07-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07697833

  3. Study start Effect of Secukinumab on Cardiorenal Outcomes in Patients With Cardiorenal Metabolic Syndrome and Atherosclerotic Cardiovascular Disease Registry record

    Expected 2026-07-15; that period ended on 2026-07-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07704190

  4. Study completion Effects of Neuromuscular Electrical Stimulation Combined With Ultrasound on Stroke Patients With Sarcopenia Registry record

    Expected 2026-07-15; that period ended on 2026-07-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07708597

  5. Study start Aspirin-Free Strategy After 3-6 Month Dual Antiplatelet Therapy in Acute Coronary Syndrome Registry record

    Expected 2026-07-15; that period ended on 2026-07-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07736196

  6. Study start Evaluating Antiplatelet and Physical Therapy for Slowing Progression in Mild Moyamoya Disease. Registry record

    Expected 2026-07-15; that period ended on 2026-07-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07762547

  7. Study completion Acetyl-leucine in Post-stroke Ataxia Registry record

    Expected 2026-07-20; that period ended on 2026-07-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07275749

  8. Study start Randomized Study of Triple Therapy vs Sildenafil Dose Optimization in Pulmonary Arterial Hypertension Registry record

    Expected 2026-07-22; that period ended on 2026-07-22.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07713914

  9. Study completion Cryotherapy for Reducing Fistula Puncture Pain in Hemodialysis Patients Registry record

    Expected 2026-07-24; that period ended on 2026-07-24.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07694271

  10. Primary completion Cryotherapy for Reducing Fistula Puncture Pain in Hemodialysis Patients Registry record

    Expected 2026-07-24; that period ended on 2026-07-24.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07694271

  11. Study start Efficacy, Safety, and Tolerability of Tirzepatide in Real-World Conditions in Paraguay. Registry record

    Expected 2026-07-27; that period ended on 2026-07-27.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07588438

  12. Study start A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Oral SAL0137 in Adults With Elevated Lp(a) and Increased Risk of Cardiovascular Events Registry record

    Expected 2026-07-27; that period ended on 2026-07-27.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07729475

  13. Study completion Effects of Modulators of Gluconeogenesis, Glycogenolysis and Glucokinase Activity Registry record

    Expected 2026-07-29; that period ended on 2026-07-29.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05098470

  14. Primary completion Pulmonary Vein Isolation Strategy of Very High Power Short Duration in Patients With Paroxysmal Atrial Fibrillation Registry record

    Expected 2026-07-30; that period ended on 2026-07-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05996159

  15. Primary completion HF-TRACK: A UK RCT of an Passive Heart Failure Monitoring and Tracking Device Registry record

    Expected 2026-07-30; that period ended on 2026-07-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06334822

  16. Primary completion Design and Application of a Home Care WeChat Mini-Program for Children After Congenital Heart Disease Surgery Registry record

    Expected 2026-07-30; that period ended on 2026-07-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07385209

  17. Study start The Prospective, Multicenter, Randomized Controlled Trial of the VentriCure Interventional Left Ventricular Assist System Registry record

    Expected 2026-07-30; that period ended on 2026-07-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07675005

  18. Study completion BEST SFA Pilot Study - Best Endovascular STrategy for Complex Lesions of the Superficial Femoral Artery Registry record

    Expected 2026-07; that period ended on 2026-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03776799

  19. Study completion Safety and Efficacy of Remote Ischemic Conditioning Treatment for Community-based Essential Hypertension Registry record

    Expected 2026-07-31; that period ended on 2026-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03945305

  20. Primary completion Safety and Efficacy of Remote Ischemic Conditioning Treatment for Community-based Essential Hypertension Registry record

    Expected 2026-07-31; that period ended on 2026-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03945305

  21. Study completion The Effect of Intradialytic Parenteral Nutrition on Nutritional Status and Quality of Life in Hemodialysis Patients Registry record

    Expected 2026-07; that period ended on 2026-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04094038

  22. Study completion A Registry Trial of The Bioheart Rapamycin Drug-Eluting Bioresorbable Coronary Stent System Registry record

    Expected 2026-07; that period ended on 2026-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04179045

  23. Primary completion Efficacy and Safety of Madalena Association in the Treatment of Type II Diabetes Mellitus Registry record

    Expected 2026-07; that period ended on 2026-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04670666

  24. Primary completion Efficacy and Safety of Piemonte Association in the Treatment of Type II Diabetes Mellitus Registry record

    Expected 2026-07; that period ended on 2026-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05028140

  25. Primary completion Randomization to Endovascular Treatment Alone or Preceded by Systemic Thrombolysis With Tenecteplase in Ischemic Stroke Registry record

    Expected 2026-07; that period ended on 2026-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05199194

  26. Primary completion Randomization to Extend Stroke Intravenous ThromboLysis In Evolving Non-Large Vessel Occlusion With TNK (RESILIENT Registry record

    Expected 2026-07; that period ended on 2026-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05199662

  27. Primary completion CAtheter-Based Ablation of Atrial Fibrillation Compared to Conventional Treatment in Patients With Heart Failure With Preserved Ejection Fraction Registry record

    Expected 2026-07; that period ended on 2026-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05508256

  28. Study start Evaluation of the Magneto eTrieve™ PE Kit for Endovascular Thrombectomy in Subjects With Acute Pulmonary Embolism Registry record

    Expected 2026-07; that period ended on 2026-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05821426

  29. Study completion Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR) Registry record

    Expected 2026-07-31; that period ended on 2026-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05887817

  30. Study completion High-Dose Atorvastatin for Vascular Wall Protection in Thrombectomy Patients Registry record

    Expected 2026-07-31; that period ended on 2026-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05912686

  31. Study completion IBS Titan™ Sirolimus-eluting Iron Bioresorbable Peripheral Scaffold System Clinical Trial Registry record

    Expected 2026-07; that period ended on 2026-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05971394

  32. Study completion Smartwatches for Detection of Atrial Fibrillation (AFib) in Secondary Prevention of Cryptogenic Stroke Registry record

    Expected 2026-07; that period ended on 2026-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06005233

  33. Primary completion IDEAL Study: Blinded RCT for the Impact of AI Model for Cerebral Aneurysms Detection on Patients' Diagnosis and Outcomes Registry record

    Expected 2026-07; that period ended on 2026-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06118840

  34. Study completion Shuxuening Injection in the Treatment With Intravenous Thrombolysis in Patients With Ischemic Stroke (SHINY) Registry record

    Expected 2026-07-31; that period ended on 2026-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06157502

  35. Primary completion Tirofiban for Successful Endovascular Stroke Thrombectomy Registry record

    Expected 2026-07-31; that period ended on 2026-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06373042

  36. Primary completion EMAGINE 2.0 - Electromagnetic Field Ischemic Stroke - Novel Subacute Treatment Registry record

    Expected 2026-07; that period ended on 2026-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06386874

  37. Study completion Effectiveness of Weight Loss Methods on Lifespan for Metabolic Syndrome Registry record

    Expected 2026-07-31; that period ended on 2026-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06410352

  38. Primary completion Comparison of the Antiplatelet Efficacy of Aspirin Combined With Clopidogrel and Aspirin Combined With Half-dose Ticagrelor in Patients With Unruptured Intracranial Aneurysms With Normal CYP2C19 Metabolizer Phenotype Registry record

    Expected 2026-07-31; that period ended on 2026-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06486363

  39. Study completion The Effect of phoSPHocreatine on mEdical Emergency Team (Met) tREated Patients Registry record

    Expected 2026-07; that period ended on 2026-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06503016

  40. Primary completion Efficacy of Self-expandable and Balloon-expandable Valves in Patients With Ascending Aortic Dilation Registry record

    Expected 2026-07-31; that period ended on 2026-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06743568

  41. Primary completion Protocol for Improvement of Therapy With Warfarin Registry record

    Expected 2026-07; that period ended on 2026-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06789588

  42. Study completion NanO2 in Large VessEL Occlusion Stroke (NOVEL) Registry record

    Expected 2026-07-31; that period ended on 2026-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06821347

  43. Primary completion NanO2 in Large VessEL Occlusion Stroke (NOVEL) Registry record

    Expected 2026-07-31; that period ended on 2026-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06821347

  44. Study completion Electronic Blood Pressure Monitor for Atrial Fibrillation Detection Registry record

    Expected 2026-07-31; that period ended on 2026-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06931288

  45. Primary completion Electronic Blood Pressure Monitor for Atrial Fibrillation Detection Registry record

    Expected 2026-07-31; that period ended on 2026-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06931288

  46. Study start TRicuspid Uk STudy Registry record

    Expected 2026-07-31; that period ended on 2026-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07133386

  47. Study start Renal Efficacy and Safety of the Novel Oral Small-Molecule GLP-1RA HRS-7535 Evaluated in Participants With Chronic Kidney Disease Registry record

    Expected 2026-07; that period ended on 2026-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07625774

  48. Study start Mazdutide for Adults With Prediabetes: A Randomized, Double-Blind, Placebo-Controlled Trial (DREAM-PRE) Registry record

    Expected 2026-07; that period ended on 2026-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07654062

  49. Study start AI-Assisted Antidiabetic Drug Consultation System for Glycemic Control in Type 2 Diabetes Patients Managed by Non-Specialist Physicians Registry record

    Expected 2026-07; that period ended on 2026-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07684690

  50. Study start Randomized Double-blind Controlled Clinical Study of SGLT-2i Combined With Probiotic Preparations in Elderly Patients With HFpEF Registry record

    Expected 2026-07; that period ended on 2026-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07687212

  51. Study start Cardiac Magnetic Resonance and Echocardiography Study With Acoramidis Registry record

    Expected 2026-07; that period ended on 2026-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07695701

  52. Primary completion Improving Outcome in Subarachnoid Hemorrhage wIth Nadroparine Registry record

    Expected 2026-08-01; that period ended on 2026-08-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04507178

  53. Study completion Does GLP-1RA Prevent Deterioration of Metabolic State in Prediabetic and Diabetic Patients Treated With Antipsychotic Medication? Registry record

    Expected 2026-08-01; that period ended on 2026-08-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04892199

  54. Study completion Ticagrelor Based De-Escalation of Dual Antiplatelet Therapy in Ischemic Stroke Registry record

    Expected 2026-08-01; that period ended on 2026-08-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06653348

  55. Primary completion Evaluation of the Effectiveness and Safety of Remote Electrocardiographic Monitoring in Patients with Atrial Fibrillation Following Ablation Therapy Registry record

    Expected 2026-08-01; that period ended on 2026-08-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06751459

  56. Study completion iTBS for Acute Ischemic Stroke After Thrombectomy Registry record

    Expected 2026-08-01; that period ended on 2026-08-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06941961

  57. Primary completion Cardiac Changes After Effective Dose Carbetocin for Elective Caesarian Section Registry record

    Expected 2026-08-01; that period ended on 2026-08-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06946589

  58. Study start A Trial of Edaravone Dexborneol in Acute Ischemic Stroke With Active Malignancy Registry record

    Expected 2026-08-01; that period ended on 2026-08-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07091994

  59. Primary completion SLGT2i for Neuroprotection in Patients With Acute Ischemic Stroke Registry record

    Expected 2026-08-01; that period ended on 2026-08-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07105917

  60. Primary completion Drug-Coated Balloon Versus Drug-eluting Stent Angioplasty for Treatment of Chronic Total Occlusion - The DCB-CTO Trial Registry record

    Expected 2026-08-01; that period ended on 2026-08-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07369765

  61. Study start Restoring Sinus Rhythm Using Dual-Shock Technique in Patients With Atrial Fibrillation Registry record

    Expected 2026-08-01; that period ended on 2026-08-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07560644

  62. Study start DP-DCT 1.0:A Comparative Clinical Study on the Effect of Dapagliflozin Combined With CGM Versus SMBG on Glycemic Control in Patients With Type 2 Diabetes Mellitus Based on the DP-DCT Platform Registry record

    Expected 2026-08-01; that period ended on 2026-08-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07595289

  63. Study start rhTNK-tPA for Acute Ischemic Stroke Under Simplified Imaging in the Extended Time Window Registry record

    Expected 2026-08-01; that period ended on 2026-08-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07606807

  64. Study start Tirzepatide on Atrial Fibrillation Recurrence After Catheter Ablation in Patients With Obesity and HFpEF Registry record

    Expected 2026-08-01; that period ended on 2026-08-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07630454

  65. Study start Oropharyngeal Flushing Suction Tube With Laryngoscope for Stroke-Associated Pneumonia Registry record

    Expected 2026-08-01; that period ended on 2026-08-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07647666

  66. Study start Comparison of Tunneled Cuffed Dialysis Catheters Versus Arteriovenous Fistulae in Elderly or Multimorbid Patients Registry record

    Expected 2026-08-01; that period ended on 2026-08-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07649083

  67. Study start Micro-axial Flow Pump-Supported PCI in Complex Coronary Artery Disease With Ischemic LV Dysfunction Registry record

    Expected 2026-08-01; that period ended on 2026-08-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07678021

  68. Study start Selection of Transcatheter Heart vaLve With Intermediate Sizing in Patients With Severe Aortic Stenosis Treated With Transcatheter Aortic Valve Replacement Registry record

    Expected 2026-08-01; that period ended on 2026-08-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07689279

  69. Study start TeleStroke-Guided Thrombolysis for Acute Ischemic Stroke in Oman Registry record

    Expected 2026-08-01; that period ended on 2026-08-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07721129

  70. Study start Smartphone Based-PPG Assessment of REconversion in Persistent Atrial Fibrillation Registry record

    Expected 2026-08-01; that period ended on 2026-08-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07752940

  71. Study start Prophylactic IABP in Delayed-Presentation Anterior STEMI Registry record

    Expected 2026-08-01; that period ended on 2026-08-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07761455

  72. Study start Icosapent Ethyl for High-Risk Coronary Plaques Assessed by 18F-NaF PET/CT Registry record

    Expected 2026-08-01; that period ended on 2026-08-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07762755

  73. Primary completion Precise Procedural and PCI Plan (P4) Registry record

    Expected 2026-08-04; that period ended on 2026-08-04.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05253677

  74. Study completion Efficacy of Transcutaneous Auricular Vagus Nerve Stimulation on Alleviating Major Depressive Disorder in Patients With Acute Coronary Syndrome After Percutaneous Coronary Intervention:A Prospective, Double-Blind,Randomized Controlled Study Registry record

    Expected 2026-08-10; that period ended on 2026-08-10.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07454070

  75. Primary completion Safety and Efficacy of Mesenchymal Stromal Cells (Amimestrocel ) in Diabetic Kidney Disease Registry record

    Expected 2026-08-15; that period ended on 2026-08-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06969807

  76. Study start Angiotensin Receptor Blocker After TAVR in Severe Aortic Stenosis With Left Ventricular Hypertrophy (ARBITAR) Registry record

    Expected 2026-08-15; that period ended on 2026-08-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07735130

  77. Study start Study on Anti-Thrombotic Regimens for Secondary Prevention in Ischemic Stroke Patients With Possible Benefit From Anticoagulation Therapy Registry record

    Expected 2026-08-15; that period ended on 2026-08-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07746882

  78. Study start Ezetimibe for Arrhythmia Recurrence After AF Ablation Registry record

    Expected 2026-08-15; that period ended on 2026-08-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07752758

  79. Study start Using Non-Invasive Mapping To Eliminate Structural Heart Disease Ventricular Tachycardia Registry record

    Expected 2026-08-15; that period ended on 2026-08-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07759427

  80. Study completion A Randomized Comparison of CLOpidogrel Monotherapy Versus Extended Dual-antiplatelet Therapy Beyond 12 Months After Implantation of Drug-eluting StEnts in High-risk Lesions or Patients; A-CLOSE Trial Registry record

    Expected 2026-08-16; that period ended on 2026-08-16.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03947229

  81. Primary completion Prospective, Post-registration, Interventional, Randomized, in Parallel Groups, Multicenter Eurasian Clinical Study of DERIVO®/DERIVO® Mini Aneurysm Embolization Device, Europe-Asia Registry record

    Expected 2026-08-17; that period ended on 2026-08-17.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06400940

  82. Study start A Phase III Study to Evaluate the Efficacy and Safety of of DR10624 in Subjects With Severe Hypertriglyceridemia Registry record

    Expected 2026-08-17; that period ended on 2026-08-17.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07693777

  83. Primary completion Argus 2.0 Adoption Study Registry record

    Expected 2026-08-19; that period ended on 2026-08-19.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07425236

  84. Study start Digital Behavioral Therapy to Reduce Diabetes and Liver Disease Risk Registry record

    Expected 2026-08-20; that period ended on 2026-08-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07032311

  85. Study completion Study of RN0361in Adult Healthy Subjects and Adult Hypertriglyceridemic Subjects Registry record

    Expected 2026-08-26; that period ended on 2026-08-26.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06471543

  86. Primary completion The Fenofibrate And Microvascular Events in Type 1 Diabetes Eye. Registry record

    Expected 2026-08-28; that period ended on 2026-08-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01320345

  87. Primary completion Low Dose Rosuvastatin Plus Ezetimibe Versus High-dose Rosuvastatin in AMI Registry record

    Expected 2026-08-30; that period ended on 2026-08-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04499859

  88. Primary completion Sirolimus-coated Balloon Versus Drug-eluting Stent in Native Coronary Vessels - TRANSFORM II Registry record

    Expected 2026-08-30; that period ended on 2026-08-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04893291

  89. Study completion Comparison of Self- and Balloon-expandable Valves in Patients With Ascending Aortic Dilation Undergoing Transcatheter Aortic Valve Replacement: The AAD-CHOICE Registry record

    Expected 2026-08-30; that period ended on 2026-08-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06009588

  90. Primary completion Comparison of Self- and Balloon-expandable Valves in Patients With Ascending Aortic Dilation Undergoing Transcatheter Aortic Valve Replacement: The AAD-CHOICE Registry record

    Expected 2026-08-30; that period ended on 2026-08-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06009588

  91. Study start Clinical Trial of Thrombectomy Systems Registry record

    Expected 2026-08-30; that period ended on 2026-08-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07749820

  92. Study start A Study to Evaluate the Efficacy and Safety of DA-302168S Tablets in Subjects With Type 2 Diabetes Registry record

    Expected 2026-08-30; that period ended on 2026-08-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07755150

  93. Study completion A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD) Registry record

    Expected 2026-08-31; that period ended on 2026-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03619850

  94. Primary completion A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD) Registry record

    Expected 2026-08-31; that period ended on 2026-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03619850

  95. Study completion Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG Registry record

    Expected 2026-08-31; that period ended on 2026-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04045665

  96. Primary completion Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG Registry record

    Expected 2026-08-31; that period ended on 2026-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04045665

  97. Study completion Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI Registry record

    Expected 2026-08-31; that period ended on 2026-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04695106

  98. Study completion Anakinra vs Prednisone to Treat Gout Flare in Patients With Chronic Kidney Disease Stage 4/5 or Renal Transplantation Registry record

    Expected 2026-08-31; that period ended on 2026-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04844814

  99. Primary completion The API-CALF Study: Apixaban to Treat Calf Vein Thrombosis Registry record

    Expected 2026-08-31; that period ended on 2026-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04981327

  100. Primary completion Durable Effect of Imeglimin on the Glycemic Control in Patients With Type 2 Diabetes Mellitus Registry record

    Expected 2026-08-31; that period ended on 2026-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05366868